Digital Breast Tomosynthesis Equipment Market to Grow with a CAGR of 9.89% through 2029

Technological advancements in imaging technology are expected to drive the Global Digital Breast Tomosynthesis Equipment Market growth in the forecast period, 2025-2029

According to TechSci Research report, “Digital Breast Tomosynthesis Equipment Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, the Global Digital Breast Tomosynthesis Equipment Market stood at USD 3.02 billion in 2023 and is anticipated to grow with a CAGR of 9.89% in the forecast period through 2029.

Breast cancer remains a significant global health concern, prompting a surge in demand for advanced diagnostic tools like digital breast tomosynthesis (DBT). This technology is increasingly favored by healthcare providers due to its enhanced capabilities in detecting breast abnormalities, vital for early intervention and improved patient outcomes. Governments, healthcare organizations, and advocacy groups worldwide are actively promoting breast cancer screening programs, emphasizing the importance of early detection. DBT's superior sensitivity and specificity make it indispensable in these initiatives, aiding in the identification of abnormalities with greater accuracy.

The rise in breast health awareness among women has further fueled the adoption of DBT equipment. Educational campaigns and advocacy efforts have highlighted the benefits of DBT in improving early detection rates and reducing false positives, empowering women to make informed decisions about their health. Reimbursement policies also play a pivotal role in driving DBT equipment adoption. Many healthcare systems and insurers recognize the clinical advantages of DBT and offer favorable reimbursement policies for screening and diagnostic procedures using this technology. These policies incentivize healthcare providers to invest in DBT equipment, further boosting market growth.

The increasing incidence of breast cancer, coupled with heightened awareness and favorable reimbursement policies, has led to a growing demand for DBT equipment. As healthcare providers continue to prioritize early detection and improved patient outcomes, the adoption of DBT is expected to rise, contributing significantly to breast cancer diagnosis and treatment worldwide.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Digital Breast Tomosynthesis Equipment Market”

The Global Digital Breast Tomosynthesis Equipment Market is segmented into product type, end user, regional distribution, and company.

Based on the end user, the global digital breast tomosynthesis (DBT) equipment market has experienced rapid growth, with the hospital segment emerging as the fastest-growing end-user segment in the forecast period. DBT technology has revolutionized breast cancer detection and diagnosis by providing three-dimensional images of the breast, offering superior sensitivity and specificity compared to traditional two-dimensional mammography. Hospitals are at the forefront of breast cancer screening and diagnosis, catering to a large patient population and offering comprehensive healthcare services. The adoption of DBT equipment in hospitals is driven by several factors contributing to its rapid market growth.

Hospitals prioritize patient care and outcomes, seeking advanced diagnostic tools to improve the accuracy of breast cancer detection. DBT's ability to detect subtle abnormalities and reduce false positives makes it an invaluable asset in hospital settings, enhancing diagnostic accuracy and patient outcomes. Government initiatives and healthcare policies promoting breast cancer screening have spurred the adoption of DBT equipment in hospitals. Many countries have implemented organized breast cancer screening programs, encouraging hospitals to invest in advanced imaging technologies like DBT to meet screening targets and improve early detection rates.

Furthermore, technological advancements and innovations in DBT equipment have made it more accessible and user-friendly for hospitals. Manufacturers have introduced compact and cost-effective DBT systems tailored to the needs of hospital settings, enabling healthcare providers to integrate DBT into their routine clinical practice seamlessly. Reimbursement policies and insurance coverage for DBT screening have incentivized hospitals to invest in this technology. Many healthcare systems provide reimbursement for DBT examinations, making it economically viable for hospitals to adopt DBT equipment and offer it as part of their breast cancer screening services.

The hospital segment's rapid growth in the DBT equipment market reflects the increasing demand for advanced breast cancer screening and diagnosis technologies in healthcare settings. As hospitals continue to prioritize early detection and improved patient outcomes, the adoption of DBT equipment is expected to accelerate further, driving market growth and innovation in breast cancer diagnostics. Overall, the hospital segment plays a pivotal role in shaping the future of the global DBT equipment market, driving advancements in breast cancer screening and improving healthcare outcomes for patients worldwide. 

Major companies operating in Global Digital Breast Tomosynthesis Equipment Market are:

• PerkinElmer Inc. (Dexela Ltd.)
• Hologic, Inc
• GE HealthCare Technologies Inc. 
• Fujifilm Holdings Corporation
• Siemens Healthineers
• General Medical Merate SpA (IMS GIOTTO SPA)
• Varex Imaging Corporation
• Trivitron Healthcare
• Metaltronica Spa
• Analogic Corporation

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The Global Digital Breast Tomosynthesis Equipment Market is poised for significant growth in the coming years. Anticipated advancements in technology, including improved image resolution and enhanced diagnostic capabilities, are expected to propel market expansion. Moreover, increasing awareness about the importance of early detection and rising incidence of breast cancer worldwide will drive demand for digital breast tomosynthesis equipment. Additionally, the integration of DBT with other imaging modalities and the emphasis on personalized medicine and precision oncology approaches are anticipated to boost market growth. Furthermore, favorable reimbursement policies and government initiatives promoting breast cancer screening programs will contribute to the market's upward trajectory.” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Digital Breast Tomosynthesis Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (2D/3D Combination Mammography Systems, Standalone 3D Mammography Systems), By End-User (Hospitals, Diagnostic Centers, Other End-Users) Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global Digital Breast Tomosynthesis Equipment Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Digital Breast Tomosynthesis Equipment Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]